PT  - JOURNAL ARTICLE
ED  - Markman, Maurie
TI  - Assessing cancer clinical trials: Will your patient benefit from a ‘breakthrough’?
DP  - 2002 May 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 368--376
VI  - 69
IP  - 5
4099  - http://www.ccjm.org/content/69/5/368.short
4100  - http://www.ccjm.org/content/69/5/368.full
SO  - Cleve Clin J Med2002 May 01; 69
AB  - Cancer patients and their families often ask their primary care physicians if a new treatment reported in the news can help them. Physicians familiar with the long and complicated process of oncologic clinical trials are in the best position to assess the potential for clinical benefit from a new antineoplastic therapy.